Discovering ERBB2 i14e as a novel isoform of ERBB2 has mechanistically shed lights on cancer cell proliferation and drug resistance, pointing to a diagnostic biomarker and therapeutic target for GBC. This evidence concerns the gene ERBB2 and cancer.